![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessEvaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics
Preclinical toxicology studies are performed prior to phase I trials with novel cancer therapeutics to identify a safe clinical starting dose and potential human toxicities. The primary aim of this study was t...
-
Article
Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump
The stability of cisplatin (DDP) solutions (1 and 1.6 mg/ml in saline-mannitol) in plastic infusion bags was studied for up to 14 days at 25° C, 37° C and 60° C. Small changes in the solution were observed, bu...
-
Article
Effect of verapamil on daunorubicin accumulation in lymphocytes isolated from patients undergoing chemotherapy
Verapamil was shown to be capable of increasing intracellular daunorubicin levels in normal lymphocytes isolated from patients undergoing chemotherapy for epithelial ovarian cancer. The extent of the increase ...
-
Article
An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin
The intrarenal localisation of platinum following the intravenous administration of platinum-195m-labelled cisplatin, iproplatin and paraplatin was studied using autoradiography. Following injection of cisplat...
-
Chapter and Conference Paper
Mechanisms of Drug Resistance in Screening
Resistance is a term which should only properly be applied to a single cell. It is the description of the sensitivity which a single cell exhibits towards a drug, applying particularly to the case where the se...
-
Article
Comparative studies of DNA cross-linking reactions following methylene dimethanesulphonate and its hydrolytic product, formaldehyde
The technique of alkaline elution was employed to study the interactions of methylene dimethane sulphonate (MDMS) and formaldehyde (HCHO) with DNA from Yoshida lymphosarcoma cells treated with these agents. MD...
-
Article
Cross-linking between histones and DNA following treatment with a series of dimethane sulphonate esters
The cross-linking on the nucleohistone to the associated DNA by a series of methaneusulphonates of the busulphan series (CH3SO2O(CH2) n OSO2CH3) from n=4–9 has been studied by ge...
-
Article
In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera
The in vivo distribution in man of the four platinum derivatives cis-dichlorodiammine platinum(II) (DDP), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (IV) (CHIP), cis-dichloro-bis-cyclopropylamin...
-
Article
Anticancer and Interferon Agents: Synthesis and Properties - Drugs and Parmacutical Sciences - Vol. 24
-
Article
Anticancer and Interferon Agents: Synthesis and Properties - Drugs and Parmacutical Sciences - Vol. 24
-
Chapter
Principles of Chemotherapy
The principles underlying the administration of cytotoxic drugs for the treatment of malignant disease differ fundamentally from those of bacterial, fungal, or antiviral infections in that it is not possible t...
-
Article
Molecular aspects of anti-cancer drug action Topics in molecular and structural biology
-
Chapter
Dialkanesulphonates and Chromatin
It was recognised by Finley and co-workers in 1964 (1) that the dialkanesulphonates were a potent group of antitumour agents which, in some but not all cases, also produced a bone marrow depressant action. The...
-
Chapter
Mechanisms of Resistance to Anticancer Agents
Resistance to antitumor agents has been known to occur within tumour tissue since its discovery by Burchenal and his colleagues in 1950. Its meaning in the experimental laboratory may differ from that in the c...
-
Article
Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum(II) (CBDCA) in cancer patients
The blood and urinary clearances of cis-diammine 1,1-cyclobutane dicarboxylate platinum(II) (CBDCA, JM8) were determined in four patients with malignancy. A 40 μCi iv injection of 191Pt/193Pt (3:1)-labelled CBDCA...
-
Article
A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II)
Three platinum derivatives, cis-dichlorodiammine platinum (II), (DDP), cis-trans-dichlorodihydroxy-bis-(isopropylamine)platinum (IV) (CHIP) and cis-dichloro-bis-cyclopropylamine platinum (II) (CP), have been p...
-
Article
Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant disease
The blood clearances of three platinum compounds, cis-dichlorodiammine platinum II (DDP), cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV (CHIP), and cis-dichloro-bis-cyclopropylamine platinum II...
-
Article
Effects of Drugs on the Cell Nucleus
-
Article
Mitomycin C. Current Status and Developments
-
Article
Moulds, Toxins and Food